Overview

NN, Inc. is a global diversified industrial company that combines advanced
engineering and production capabilities with in-depth materials science
expertise to design and manufacture high-precision components and assemblies
primarily for the electrical, automotive, general industrial, aerospace,
defense, and medical markets. As used in this Quarterly Report, the terms "NN,"
the "Company," "we," "our," or "us" refer to NN, Inc. and its subsidiaries.
Forward-Looking Statements
This Quarterly Report contains forward-looking statements that are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These statements may discuss goals, intentions and expectations as to
future trends, plans, events, results of operations or financial condition, or
state other information relating to NN, Inc., based on current beliefs of
management as well as assumptions made by, and information currently available
to, management. Forward-looking statements generally will be accompanied by
words such as "anticipate," "believe," "could," "estimate," "expect,"
"forecast," "guidance," "intend," "may," "possible," "potential," "predict,"
"project" or other similar words, phrases or expressions. Forward-looking
statements involve a number of risks and uncertainties that are outside of
management's control and that may cause actual results to be materially
different from such forward-looking statements. Such factors include, among
others, general economic conditions and economic conditions in the industrial
sector; the impacts of the COVID-19 pandemic on the Company's financial
condition, business operations and liquidity; competitive influences; risks that
current customers will commence or increase captive production; risks of
capacity underutilization; quality issues; availability of raw materials;
currency and other risks associated with international trade; our dependence on
certain major customers, some of whom are not parties to long-term agreements
(and/or are terminable on short notice); the impact of acquisitions and
divestitures; the level of our indebtedness; the restrictions contained in our
debt agreements; our ability to obtain financing at favorable rates, if at all,
and to refinance existing debt as it matures; unanticipated difficulties
integrating acquisitions; new laws and governmental regulations; and other risk
factors and cautionary statements listed from time-to-time in our periodic
reports filed with the Securities and Exchange Commission. We disclaim any
obligation to update any such factors or to publicly announce the result of any
revisions to any of the forward-looking statements included herein or therein to
reflect future events or developments.
For additional information concerning such risk factors and cautionary
statements, please see the sections titled "Item 1A. Risk Factors" in the 2020
Annual Report and this Quarterly Report.
Results of Operations
Factors That May Influence Results of Operations
The following paragraphs describe factors that have influenced results of
operations for the six months ended June 30, 2021, that management believes are
important to provide an understanding of the business and results of operations
or that may influence operations in the future.
Global COVID-19 Pandemic
The COVID-19 pandemic continues to disrupt the United States and global economy,
and we cannot predict when a full economic recovery will occur. Although product
volumes are beginning to return to more normalized levels and our operating
results in 2021 reflect momentum in the recovery of our business from the
effects of the COVID-19 pandemic, a new Delta variant of COVID-19, which appears
to be the most transmissible variant to date, has begun to spread in the United
States and across the globe. The impact of the Delta variant cannot be predicted
at this time and could depend on numerous factors, including vaccination rates
among the population, the effectiveness of COVID-19 vaccines against the Delta
variant, and the response by governmental bodies and regulators. Further surges
in COVID-19 infection rates could result in the reinstatement of directives and
mandates requiring businesses to again curtail or cease normal operations. The
spread of COVID-19 and the responses thereto have created a disruption in the
manufacturing, delivery, and overall supply chain of automobile manufacturers
and suppliers, as well as disruption within the power industry. Global vehicle
production decreased significantly in 2020, but production has since ramped back
up. Disruptions of normal supply chains have caused challenges in obtaining raw
materials we use in the manufacture of some of our products. We have been
increasing our inventories in the current year to mitigate the risk of supply
chain disruption for our customers. A worldwide semiconductor chip shortage is
beginning to affect automotive original equipment manufacturers, causing
unpredictable volumes. The rapid development and fluidity of the situation
precludes any prediction as to the ultimate impact COVID-19 will have on our
business, financial condition, results of operations, and cash flows, which will
depend largely on future developments directly or indirectly relating to the
duration and scope of the COVID-19 pandemic.
While managing decreased demand in many regions across the globe, we are now
operating at all of our business locations. We have implemented training and
recruiting programs to address labor shortages. We are focused on the safety of
our employees, customers, and suppliers. We have developed and implemented
processes to ensure a safe environment for our employees and
                                       30
--------------------------------------------------------------------------------
  Table of Contents
any visitors to our facilities, including providing personal protective
equipment and establishing social distancing protocols and temperature checks.
We are actively promoting vaccination among our employees. These processes
include recommendations based on guidelines from the Centers for Disease Control
and Prevention and the World Health Organization. The health and safety of our
employees remains our top priority.
We have undertaken a number of permanent and temporary actions to manage the
evolving situation, as described in our 2020 Annual Report. We continue to
streamline facilities and implement cost savings initiatives. Capital
expenditures and travel costs remain at relatively low levels. We refinanced our
credit facility and preferred stock in the first quarter as discussed below.
Credit Facilities
On March 22, 2021, we entered into a new $150.0 million term loan facility (the
"Term Loan Facility") and a new $50.0 million asset backed credit facility (the
"ABL Facility"). The proceeds from the Term Loan Facility were used to prepay
the amounts outstanding on our previous term loans. The previous credit facility
was terminated and consisted of a Senior Secured Term Loan, Incremental Term
Loan, and Senior Secured Revolver. No amounts were outstanding on the Senior
Secured Revolver at the time of termination.
Outstanding borrowings under the Term Loan Facility bear interest at either 1)
one-month LIBOR (subject to a 1.000% floor) plus an applicable margin of 6.875%
or 2) the greater of various benchmark rates plus an applicable margin of
5.875%. At June 30, 2021, the Term Loan Facility bore interest, based on
one-month LIBOR, at 7.875%. The Term Loan Facility requires quarterly principal
payments of $0.4 million with the remaining unpaid principal amount due on the
final maturity date of September 22, 2026. The Term Loan Facility is
collateralized by all of our assets. The Term Loan Facility has a first lien on
all assets other than accounts receivable and inventory and has a second lien on
accounts receivable and inventory. We were in compliance with all requirements
under the Term Loan Facility as of June 30, 2021.
The ABL Facility provides for a senior secured revolving credit facility in the
amount of $50.0 million, of which $30.0 million is available in the form of
letters of credit and $5.0 million is available for the issuance of short-term
swingline loans. The availability of credit under the ABL Facility is limited by
a borrowing base calculation derived from accounts receivable and inventory held
in the United States. Outstanding borrowings under the ABL Facility bear
interest on a variable rate structure plus an interest rate spread that is based
on the average amount of aggregate revolving commitment available. The variable
borrowing rate is either 1) LIBOR plus an applicable margin of 1.75% or 2.00%,
depending on availability, or 2) the greater of the federal funds rate or prime,
plus an applicable margin of 0.75% or 1.00%, depending on availability. We may
elect whether to use one-month, three-month, or six-month LIBOR, subject to a
0.50% floor. Interest payments are due monthly on borrowings that utilize
one-month LIBOR and quarterly on borrowings that utilize three-month or
six-month LIBOR. At June 30, 2021, using one-month LIBOR plus a 1.75% spread,
the weighted average interest rate on outstanding borrowings under the ABL
Facility would have been 2.25% if there had been any balance outstanding. We pay
a commitment fee of 0.375% for unused capacity under the ABL Facility and a
0.125% fee on the amount of letters of credit outstanding. The final maturity
date of the ABL Facility is March 22, 2026.
We had no outstanding borrowings under the ABL Facility at June 30, 2021. Total
capacity under the ABL Facility was $44.2 million as of June 30, 2021, of which
$30.2 million was available for future borrowings after reductions for
outstanding letters of credit as of June 30, 2021. The ABL Facility has a first
lien on accounts receivable and inventory. We were in compliance with all
requirements under the ABL Facility as of June 30, 2021.
Preferred Stock
On March 22, 2021, we completed a private placement of 65 thousand shares of
newly designated Series D Perpetual Preferred Stock, with a par value of $0.01
per share (the "Series D Preferred Stock"), at a price of $1,000 per share,
together with detachable warrants (the "2021 Warrants") to purchase up to
1.9 million shares of our common stock at an exercise price of $0.01 per share.
The Series D Preferred Stock has an initial liquidation preference of $1,000 per
share and is redeemable at our option in cash at a redemption price equal to the
liquidation preference then in effect. Series D Preferred Stock shares earn cash
dividends at a rate of 10.0% per year, payable quarterly in arrears, accruing
whether or not earned or declared. If no cash dividend is paid, then the
liquidation preference per share effective on the dividend date increases by
12.0% per year. On March 22, 2026, the cash dividend rate and in-kind dividend
rate increase by 2.5% per year. Cash dividends are required beginning on
September 30, 2027.
Net cash proceeds of $61.8 million from the issuance of the Series D Preferred
Stock, along with part of the proceeds from the Term Loan Facility, were used to
redeem all of the outstanding shares of the Company's Series B Convertible
Preferred Stock (the "Series B Preferred Stock"). The total redemption cash
payment was $118.4 million.
                                       31
--------------------------------------------------------------------------------
  Table of Contents
Sales Concentration
We recognized sales from a single customer of $13.2 million, or 11% and $26.2
million, or 11%, of consolidated net sales, during the three and six months
ended June 30, 2021, respectively. We recognized sales from this customer of
$9.2 million, or 12% of consolidated net sales, during the three months ended
June 30, 2020. Revenues from this customer are primarily in our Mobile Solutions
segment.

Three Months Ended June 30, 2021, compared to the Three Months Ended June 30, 2020

Three Months Ended June 30,


                                                                  2021               2020                  $ Change
Net sales                                                     $ 123,157          $  78,532          $ 44,625

Organic growth                                                                                                  $ 42,123
Foreign exchange effects                                                                                           2,502
Cost of sales (exclusive of depreciation and
amortization shown separately below)                             99,797             65,058            34,739

Selling, general, and administrative expense                     13,585             14,273              (688)

Depreciation and amortization                                    11,687             11,327               360

Other operating income, net                                        (324)              (949)              625
Loss from operations                                             (1,588)           (11,177)            9,589
Interest expense                                                  3,573              6,356            (2,783)

Other expense (income), net                                       1,680             (1,215)            2,895

Loss from continuing operations before benefit (provision) for income taxes and share of net income from joint venture

                                               (6,841)           (16,318)            9,477
Benefit (provision) for income taxes                                231             (2,175)            2,406
Share of net income from joint venture                            1,219                927               292
Loss from continuing operations                                  (5,391)           (17,566)           12,175
Loss from discontinued operations, net of tax                         -             (4,182)            4,182
Net loss                                                      $  (5,391)         $ (21,748)         $ 16,357


Net Sales. Net sales increased by $44.6 million, or 57%, during the three months
ended June 30, 2021, compared to the three months ended June 30, 2020, primarily
due to higher demand within all markets that were negatively impacted by the
COVID-19 pandemic in the prior year and new business in the general industrial
market. In addition, sales were positively impacted by increased selling prices
for precious metals allowed under customer contracts due to the sharp rise in
underlying commodities costs compared with the same period of 2020. These
increases were partially offset by decreased demand for smart meter components
due to inventory adjustments at a key customer. Sales of components to the
medical industry experienced recovery in the current period compared to the same
period of 2020 when many elective surgeries were delayed as a result of the
COVID-19 pandemic. We also realized favorable foreign exchange effects of $2.5
million.
Cost of Sales. Cost of sales increased by $34.7 million, or 53%, during the
three months ended June 30, 2021, compared to the three months ended June 30,
2020, primarily due to variable costs associated with the above-noted sales
increase. In addition, cost of sales increased due to the reintroduction of
employee-related costs suspended in the prior year due to the pandemic, such as
benefits and overtime hours. These increases were partially offset by favorable
overhead absorption due to the increase in inventory.
Selling, General, and Administrative Expense. Selling, general, and
administrative expense decreased by $0.7 million during the three months ended
June 30, 2021, compared to the three months ended June 30, 2020, primarily due
to cost reduction initiatives that drove decreases in personnel and professional
fees.
Other Operating Income, Net. Other operating income, net, changed unfavorably by
$0.6 million primarily due to a gain on the sale of a building in Fairfield,
Ohio, during the three months ended June 30, 2020.
Interest Expense.  Interest expense decreased by $2.8 million during the three
months ended June 30, 2021, compared to the three months ended June 30, 2020,
primarily due to settlements on the interest rate swap in the prior year that
were recognized in interest expense while the hedge was effective.
                                       32

--------------------------------------------------------------------------------


  Table of Contents
                                                                             Three Months Ended June 30,
                                                                              2021                  2020
Interest on debt                                                        $        3,110          $    2,304
Interest rate swap settlements                                                       -               3,436
Amortization of debt issuance costs and discount                                   313                 445
Capitalized interest                                                               (80)                (45)
Other                                                                              230                 216
Total interest expense                                                  $  

3,573 $ 6,356




Other Expense (Income), Net. Other expense (income), net, changed unfavorably by
$2.9 million during the three months ended June 30, 2021, compared to the three
months ended June 30, 2020, due to noncash derivative mark-to-market losses,
less favorable foreign exchange effects associated with intercompany borrowings,
and a litigation settlement reached during the current quarter.
Benefit (Provision) For Income Taxes. Our effective tax rate was 3.4% for the
three months ended June 30, 2021, compared to (13.3)% for the three months ended
June 30, 2020. The difference in rates is primarily due to the estimated impacts
of GILTI and the CARES Act. Note 8 in the Notes to Condensed Consolidated
Financial Statements describes the effective income tax rate for each period
presented.
Share of Net Income from Joint Venture. Our share of net income from the joint
venture increased during the three months ended June 30, 2021, compared to the
three months ended June 30, 2020, primarily due to improved profits resulting
from higher sales volumes, expanding variable margins as a result of successful
process improvement initiatives and improved product mix, and fixed cost
reduction actions.
Results by Segment
MOBILE SOLUTIONS
                                              Three Months Ended June 30,
                                      2021          2020             $ Change
Net sales                          $ 73,886      $ 41,037      $ 32,849

Organic growth                                                            $ 31,013
Foreign exchange effects                                                     1,836
Income (loss) from operations      $  2,509      $ (4,592)     $  7,101


Net sales increased by $32.8 million during the three months ended June 30,
2021, compared to the three months ended June 30, 2020, primarily due to higher
demand within all markets which were negatively impacted by the COVID-19
pandemic in the prior year, new business in the general industrial market, and
favorable foreign exchange effects of $1.8 million.
Income from operations increased by $7.1 million during the three months ended
June 30, 2021, compared to the same period in the prior year primarily due to
the contribution generated from the above-noted sales increase. Moreover, we
built up inventory in the three months ended June 30, 2021, which resulted in
favorable overhead absorption during the quarter. These positive impacts were
partially offset by the reintroduction of employee-related costs suspended in
the prior year due to the pandemic, such as travel, benefits and overtime hours.
POWER SOLUTIONS
                                         Three Months Ended June 30,
                                 2021          2020             $ Change
Net sales                     $ 49,271      $ 37,491      $ 11,780

Organic growth                                                       $ 11,114
Foreign exchange effects                                                  666

Income from operations        $  2,875      $  1,454      $  1,421


Net sales increased by $11.8 million during the three months ended June 30,
2021, compared to the three months ended June 30, 2020 primarily due to higher
demand within the end markets which were negatively impacted by the COVID-19
pandemic in the prior year. Sales were also positively impacted by increased
selling prices for precious metals allowed under customer contracts due to the
sharp rise in underlying commodities costs compared with the same period in
2020. Sales of components to
                                       33
--------------------------------------------------------------------------------
  Table of Contents
the medical industry experienced recovery in the current period compared to the
same period of 2020 when many elective surgeries were delayed as a result of the
COVID-19 pandemic.
Income from operations increased by $1.4 million compared to the same period in
the prior year primarily due to the contribution generated from the above-noted
sales increase, partially offset by the reintroduction of employee-related costs
suspended in the prior year due to the pandemic, such as travel, benefits and
overtime hours.
Six Months Ended June 30, 2021, compared to the Six Months Ended June 30, 2020

Six Months Ended June 30,


                                                            2021               2020                    $ Change
Net sales                                               $ 249,961          $  194,745          $  55,216

Organic growth                                                                                              $  53,371
Foreign exchange effects                                                                                        1,845
Cost of sales (exclusive of depreciation and
amortization shown separately below)                      199,485             159,536             39,949

Selling, general, and administrative expense               28,160              30,433             (2,273)

Depreciation and amortization                              23,255              22,684                571

Goodwill impairment                                             -              92,942            (92,942)
Other operating expense (income), net                        (329)              4,177             (4,506)
Loss from operations                                         (610)           (115,027)           114,417
Interest expense                                            5,597              10,163             (4,566)
Loss on extinguishment of debt and write-off of
debt issuance costs                                         2,390                   -              2,390
Derivative payments on interest rate swap                   1,717                   -              1,717
Loss on interest rate swap                                  2,033                   -              2,033
Other expense, net                                          1,558                 329              1,229
Loss from continuing operations before benefit
(provision) for income taxes and share of net
income from joint venture                                 (13,905)           (125,519)           111,614
Benefit (provision) for income taxes                          987                (780)             1,767
Share of net income from joint venture                      2,614                 656              1,958
Loss from continuing operations                           (10,304)           (125,643)           115,339
Loss from discontinued operations, net of tax                   -            (144,296)           144,296
Net loss                                                $ (10,304)         $ (269,939)         $ 259,635


Net Sales. Net sales increased by $55.2 million, or 28%, during the six months
ended June 30, 2021, compared to the six months ended June 30, 2020, primarily
due to higher demand within all markets that were negatively impacted by the
COVID-19 pandemic in the prior year and favorable foreign exchange effects of
$1.8 million. In addition, sales were positively impacted by increased selling
prices for precious metals allowed under customer contracts due to the sharp
rise in underlying commodities costs compared with the same period of 2020.
Cost of Sales.  Cost of sales increased by $39.9 million, or 25%, during the six
months ended June 30, 2021, compared to the six months ended June 30, 2020,
primarily due to variable costs associated with the above-noted sales increase.
In addition, cost of sales increased due to the reintroduction of
employee-related costs suspended in the prior year due to the pandemic, such as
travel, benefits and overtime hours, which was partially offset by favorable
overhead absorption due to the increase in inventory.
Selling, General, and Administrative Expense.  Selling, general, and
administrative expense decreased by $2.3 million during the six months ended
June 30, 2021, compared to the six months ended June 30, 2020, primarily due to
cost reduction initiatives that drove decreases in personnel costs and
professional fees.
Goodwill Impairment. We recognized goodwill impairment of $92.9 million at Power
Solutions in 2020, resulting in no remaining goodwill balance.
Other Operating Expense (Income), Net. Other operating expense (income), net,
changed favorably by $4.5 million primarily due to charges and costs associated
with asset disposals and elimination of a portion of our lease obligation as a
result of our
                                       34
--------------------------------------------------------------------------------
  Table of Contents
decision to vacate a portion of our corporate headquarters building in 2020.
These charges were partially offset by a gain on the sale of a building in
Fairfield, Ohio, in the second quarter of 2020.
Interest Expense.  Interest expense decreased by $4.6 million during the six
months ended June 30, 2021, compared to the six months ended June 30, 2020,
primarily due to settlements on the interest rate swap the prior year that were
recognized in interest expense while the hedge was effective.
                                                            Six Months Ended June 30,
                                                                2021                 2020
Interest on debt                                      $      4,549                $  4,155
Interest rate swap settlements                                   -          

4,806


Amortization of debt issuance costs and discount               718                     871
Capitalized interest                                          (111)                   (134)
Other                                                          441                     465
Total interest expense                                $      5,597                $ 10,163


Loss on Extinguishment of Debt and Write-off of Debt Issuance Costs. We
recognized $2.4 million for the write-off of unamortized debt issuance costs
that were associated with the credit facility that was terminated in March 2021.
Derivative Payments on Interest Rate Swap. Derivative payments on interest rate
swap represent cash settlements of the interest rate swap after hedge accounting
was discontinued in October 2020. Prior to October 2020, interest rate swap
settlements were recognized in interest expense. The interest rate swap was
terminated in the first quarter of 2021.
Loss on Interest Rate Swap. Loss on interest rate swap represents mark-to-market
adjustments on the interest rate swap after hedge accounting was discontinued in
October 2020 as well as amortization of the residual loss in accumulated other
comprehensive income as monthly settlements occur. Prior to October 2020,
mark-to-market adjustments on the interest rate swap were recognized in
accumulated other comprehensive income. Upon termination of the interest rate
swap in March 2021, we recognized in earnings the remaining $3.3 million loss
that had been deferred in accumulated other comprehensive income.
Other Expense, Net. Other expense, net, changed unfavorably by $1.2 million
during the six months ended June 30, 2021, compared to the six months ended June
30, 2020, due to a litigation settlement reached during the current quarter,
partially offset by more favorable foreign exchange effects associated with
intercompany borrowings.
Benefit (Provision) for Income Taxes. Our effective tax rate was 7.1% for the
six months ended June 30, 2021, compared to (0.6)% for the six months ended June
30, 2020. The difference in rates is primarily due to the estimated impacts of
GILTI and the CARES Act. Note 8 in the Notes to Condensed Consolidated Financial
Statements describes the effective income tax rate for each period presented.
Share of Net Income from Joint Venture. Share of net income from the JV
increased during the six months ended June 30, 2021, compared to the six months
ended June 30, 2020, primarily due to improved profits from expanding variable
margins as a result of successful process improvement initiatives and improved
product mix, and fixed cost reduction actions.
Results by Segment
MOBILE SOLUTIONS
                                                Six Months Ended June 30,
                                      2021           2020              $ Change
Net sales                          $ 151,662      $ 110,921      $ 40,741

Organic growth                                                              $ 39,589
Foreign exchange effects                                                       1,152

Income (loss) from operations      $   8,599      $  (4,328)     $ 12,927


Net sales increased by $40.7 million during the six months ended June 30, 2021,
compared to the six months ended June 30, 2020, primarily due to higher demand
within all markets which were negatively impacted by the COVID-19 pandemic in
the prior year, new business in the general industrial market, and favorable
foreign exchange effects.
Income (loss) from operations increased by $12.9 million compared to the same
period in the prior year primarily due to contribution generated from the
above-noted sales increase. Moreover, we built up inventory in the six months
ended June 30, 2021, which resulted in favorable overhead absorption during the
period. These positive impacts were partially offset by the reintroduction of
employee-related costs suspended in the prior year due to the pandemic, such as
travel, benefits and overtime hours.
                                       35

--------------------------------------------------------------------------------


  Table of Contents

POWER SOLUTIONS
                                               Six Months Ended June 30,
                                      2021          2020              $ Change
Net sales                          $ 98,346      $  83,892      $ 14,454

Organic growth                                                             $ 13,761
Foreign exchange effects                                                        693
Goodwill impairment                $      -      $ (92,942)     $ 92,942
Income (loss) from operations      $  5,307      $ (88,880)     $ 94,187


Net sales increased by $14.5 million during the six months ended June 30, 2021,
compared to the six months ended June 30, 2020, primarily due to higher demand
within the end markets which were negatively impacted by the COVID-19 pandemic
in the prior year. Sales were also positively impacted by increased selling
prices for precious metals allowed under customer contracts due to the sharp
rise in underlying commodities costs compared to the same period of 2020.
Income (loss) from operations increased by $94.2 million compared to the same
period in the prior year primarily due to a goodwill impairment loss of $92.9
million recognized in the first quarter of 2020. In addition, income from
operations increased due to the contribution generated from the above-noted
sales increase and higher precious metals commodities prices. These favorable
impacts were partially offset by the reintroduction of employee-related costs
suspended in the prior year due to the pandemic, such as travel, benefits and
overtime hours.
Changes in Financial Condition from December 31, 2020, to June 30, 2021
Overview
From December 31, 2020, to June 30, 2021, total assets decreased by $11.4
million primarily due to normal depreciation and amortization of fixed assets,
lease right-of-use assets, and intangible assets. These decreases were partially
offset by capital expenditures and increases in inventories during the six
months ended June 30, 2021. Inventories increased as a result of a strategic
decision to mitigate potential supply chain issues for our customers.
From December 31, 2020, to June 30, 2021, total liabilities increased by $66.4
million, primarily due to the refinancing of our credit facilities and redeeming
the Series B Preferred Stock with debt.
Working capital, which consists of current assets less current liabilities, was
$122.5 million as of June 30, 2021, compared to $112.0 million as of December
31, 2020. The increase in working capital was primarily due to the increase in
inventories discussed above.
Cash Flows
Cash provided by operations was $5.9 million for the six months ended June 30,
2021, compared with cash provided by operations of $15.9 million for the six
months ended June 30, 2020. The difference was primarily due to $8.0 million in
current year income tax payments and building inventory levels during the
current year to mitigate potential supply chain issues for our customers.
Cash used in investing activities was $30.2 million for the six months ended
June 30, 2021, compared with cash used in investing activities of $12.5 million
for the six months ended June 30, 2020. The difference was primarily due to cash
paid to settle the interest rate swap and post-closing adjustment on the sale of
the Life Sciences business, partially offset by lower capital expenditures in
the current year.
Cash provided by financing activities was $6.9 million for the six months ended
June 30, 2021, compared with cash provided by financing activities of $53.4
million for the six months ended June 30, 2020. The difference was primarily due
to $11.9 million net inflow from the debt and preferred stock refinancing in the
current year compared to the $62.5 million draw on the Senior Secured Revolver
in the prior year.

Liquidity and Capital Resources
Credit Facilities
The principal amount outstanding under our Term Loan Facility as of June 30,
2021, was $149.6 million, without regard to unamortized debt issuance costs and
discount. As of June 30, 2021, we had unused borrowing capacity of $30.2 million
under
                                       36

--------------------------------------------------------------------------------


  Table of Contents
the ABL Facility, subject to certain limitations. This amount of borrowing
capacity is net of $14.0 million of outstanding letters of credit at June 30,
2021, which are considered as usage of the ABL Facility. This amount includes
approximately $0.8 million of duplicate letters of credit that remained
outstanding at June 30 but were terminated during the third quarter after
transition to a new guarantor bank was completed.
The Term Loan Facility requires quarterly principal payments of $0.4 million
with the remaining unpaid principal amount due on the final maturity date of
September 22, 2026. If one-month LIBOR is less than 1.00%, then we pay 7.875%
per annum in interest. If one-month LIBOR exceeds 1.000%, then we pay the
variable one-month LIBOR plus an applicable margin of 6.875%. Based on the
interest rate in effect at June 30, 2021, annual interest payments would be
approximately $11.8 million. On July 22, 2021, we entered into a new interest
rate swap as discussed in Note 18 to the Notes to Condensed Consolidated
Financial Statements included in this Quarterly Report. Based on the interest
rate in effect at June 30, 2021, and the fixed rate on the new interest rate
swap, annual interest payments would be approximately $12.0 million.
The ABL Facility bears interest on a variable rate structure with borrowings
bearing interest at one-month LIBOR plus an applicable margin of 1.75%. The
interest rate in effect at June 30, 2021, was 2.25%. We pay a commitment fee of
0.375% for unused capacity under the ABL Facility.
We were in compliance as of June 30, 2021, with all requirements under our Term
Loan Facility and ABL Facility. Both credit facilities allow for optional
expansion of available borrowings, subject to certain terms and conditions.
Seasonality and Fluctuation in Quarterly Results
General economic conditions impact our business and financial results, and
certain businesses experience seasonal and other trends related to the
industries and end markets that they serve. For example, European sales are
often weaker in the summer months as customers slow production and sales to
original equipment manufacturers are often stronger immediately preceding and
following the launch of new products. However, as a whole, we are not materially
impacted by seasonality.
Off-Balance Sheet Arrangements
We are not a party to any off-balance sheet arrangements that have, or are
reasonably likely to have, a material current or future effect on our financial
condition, revenues or expenses, results of operations, liquidity, capital
expenditures, or capital resources.
Critical Accounting Policies
Our critical accounting policies, including the assumptions and judgments
underlying them, are disclosed in the 2020 Annual Report, including those
policies as discussed in Note 1 to the Notes to Consolidated Financial
Statements included in the 2020 Annual Report. There have been no changes to
these policies during the six months ended June 30, 2021, except as discussed in
Note 1 to the Notes to Condensed Consolidated Financial Statements included in
this Quarterly Report.
Recent Accounting Pronouncements
See Note 1 in the Notes to Condensed Consolidated Financial Statements included
in this Quarterly Report.

© Edgar Online, source Glimpses